The anti-tumour effect of ApoA1 was achieved primarily through modulation of both the innate and adaptive immune response and reducing the expression and activity level of the extracellular matrix degrading enzyme matrix metalloproteinase-9 and the anti-apoptotic protein survivin within the tumour bed [122, 150]. Here, MMP9 is linked to neoplasm.